Cel-Sci Share Price
AMEX: CVM | Micro Cap | HealthcareCel-Sci Stock Performance
Cel-Sci Share Price Today
As of 19 November 2026, Cel-Sci Corporation's share price is $1.40. The stock opened at $1.61, compared to its previous close of $1.83. During today's trading session, Cel-Sci Corporation's share price traded between $1.34 and $1.61, with an average price of $1.48. Over the past 52 weeks, the stock has recorded a high of $7.75 and a low of $0.90. In terms of performance, Cel-Sci Corporation's share price has declined by 9.09% over the last six months and is down 81.75% on a year-on-year basis.
Cel-Sci Share Price Chart
Cel-Sci Quarterly Profit & Loss
All figures in USD
Cel-Sci Annual Profit & Loss
All figures in USD
Cel-Sci Balance Sheet
All figures in USD Million
Cel-Sci Cash Flow
All figures in USD Million
Corporate Actions
About Cel-Sci
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Cel-Sci Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.44 | $1.40 | +0.36% |
Oct 2026 | $2.10 | $1.39 | -32.85% |
Sep 2026 | $1.58 | $2.07 | +27.78% |
Aug 2026 | $1.19 | $1.62 | +39.06% |
Jul 2026 | $1.05 | $1.17 | +10.95% |
Jun 2026 | $1.46 | $1.05 | -31.82% |
May 2026 | $2.83 | $1.54 | -51.11% |
Apr 2026 | $3.38 | $3.15 | +3.28% |
Mar 2026 | $3.77 | $3.05 | -27.21% |
Feb 2026 | $5.48 | $4.19 | -27.13% |
Jan 2026 | $5.33 | $5.75 | +6.48% |
Dec 2025 | $7.11 | $5.40 | -29.60% |